At Diaverum, ESG is woven through our company strategy and operations, ensuring we take a stakeholder-centric approach in the way we do business.

We are therefore integrating the Sustainable Development Goals (United Nations 2030 Agenda) into our business development plans, and are signatories of the Ethical Principles in Health Care (EPiHC) – aligning our ESG framework to both.

You can read more about our commitment and progress in our ESG Report, downloadable at the bottom of this page.

"As healthcare systems worldwide seek more sustainable and equitable ways to deliver care, Diaverum is ready to lead - with Competence, Passion, and Inspiration. Our ambition is clear: to evolve from a treatment provider to an enabler of fulfilling lives. That means supporting patients beyond the dialysis chair, strengthening health systems, and embedding sustainability into every decision we make. With the support of M42, we are helping shape a future where care is smart, digital, inclusive - and enduring. "
Our ESG priority areas

Discover more

Our ESG priority areas

We prioritize our ESG initiatives through 5 different pillars: Environment, Access to care, Patients, Operating Responsibly, Employees and well-being. For each pillar, we define global ambitions and targets, setting a benchmark for our performance. By measuring our progress and assessing our impact, we ensure accountability and transparency. These efforts enable us to continuously improve our practices and drive positive change.

Read more
Sustainable Development Goals

Discover more

Sustainable Development Goals

At Diaverum, we're committed to the SDGs. Through our initiatives, we promote good health (SDG 3), quality education (SDG 4), decent work (SDG 8), and responsible consumption (SDG 12). By aligning our efforts with these SDGs, we aim to create a positive impact and contribute to a sustainable future for all.

Read more

Diaverum in numbers

450

Clinics around the world

24

Globally present in 24 countries across four continents

13,500

Staff worldwide (approx.)

42,000

Patients (approx.)

6.5

Million treatments annually (approx.)